You are here

Scemblix

Novartis gets FDA okay for frontline use of Scemblix in CML

Pharmaphorum

Wed, 10/30/24 - 11:38 am

Novartis study points to larger role for targeted leukemia drug

BioPharma Dive

Fri, 05/31/24 - 10:50 am

clinical trials

Novartis’ Scemblix meets primary endpoints in Phase III leukemia trial

Clinical Trials Arena

Mon, 01/8/24 - 11:41 am

clinical trials

ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data

Fierce Pharma

Fri, 05/27/22 - 10:21 am

chronic myeloid leukemia

FDA Approves Scemblix for Pretreated CML in the Chronic Phase

Cure Today

Sat, 10/30/21 - 10:46 pm